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Abstract 
Our previous studies revealed that pregnancy associated breast cancer (PABC) had signifi-
cantly reduced nuclear p63 expression in myoepithelia, while intense cytoplasmic p63 ex-
pression in associated epithelia. Our current study assessed these epithelia using immuno-
histochemistry with a panel of aggressiveness and invasiveness related markers and com-
parative genomic hybridization (array-CGH) with over 30,000 DNA probes. These epithelia 
showed several unique alterations, including (1) immunohistochemical and morphological 
resemblance to invasive cancer, (2) significant gain in copy numbers of DNA coding genes for 
morphogenesis, angiogenesis, and metastasis, and (3) significant loss in copy numbers of DNA 
coding genes for tumor suppressors, cell adhesion, and macromolecular complex assembly or 
intra-cellular trafficking. Detected array-CGH alterations correlated well with in vivo ex-
pression of a number of corresponding proteins tested. These findings suggest that aberrant 
sub-cellular localization of p63 expression in normal or hyperplastic appearing epithelial cells 
may significant contribute to increased invasiveness and aggressiveness of these cells. 
Key words: breast epithelia, pregnancy associated breast cancer, p63 expression, invasiveness and 
aggressiveness. 
Introduction 
Pregnancy-associated breast cancer (PABC), 
which occurs during pregnancy or within one year of 
delivery, is the second most common cancer in preg-
nant women [1-3]. A normal full-term pregnancy is 
believed to be one of the most effective means to de-
crease the lifetime-risk of breast cancer, whereas 
PABC is associated with the most aggressive clinical 
course and the highest mortality rate among breast 
malignancies [1-3]. These seemingly conflicting im-
pacts are believed to result from aberrant proliferation 
and differentiation of stem cells, and pathological 
alterations of the microenvironment and extracellular 
matrix [3,4]. Neither the molecular or cellular me-
chanisms, nor the specific molecules linking to ag-
gressiveness and invasiveness of PABC, however, 
have been identified.  
Promoted by the fact that the myoepithelium is 
the sole source of several tumor suppressors, includ-
ing maspin, Wilms’ tumor 1 (WT-1), p63, and p73, 
which show significant paracrine inhibition on tumor 
cell growth and invasion in vitro [5-10], our recent 
studies compared the expression of these tumor sup-Int. J. Biol. Sci. 2010, 6 
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pressors in PABC and the stage, grade, and age 
matched non-PABC. PABC were found to have sev-
eral unique alterations, including (1) the absence of 
p63 and WT-1 expression in a vast majority of myoe-
pithelial cells, and (2) intense cytoplasmic p63 ex-
pression in a subset of normal or hyperplastic epi-
thelial cells, which are arranged as segregated clusters 
or lobules [11].  
Our findings appear to have significant scientific 
and clinical implications for several reasons. First, as 
the p63 gene encodes multiple protein isoforms that 
regulate p53, p73, and other tumor suppressors 
[12,13], aberrant p63 expression may result in aberrant 
expression of these tumor suppressors. Second, as p63 
is required for normal development of the breast and 
other organs [12,13], aberrant p63 expression may 
result in structural defects of breast tissues, making 
them more acceptable to external or internal insults 
that promote carcinogenesis. Third, as cytoplasmic 
p63 expression is associated with poorer patient sur-
vival in lung cancer and tumor grade in meningiomas 
[14,15], aberrant p63 expression may have oncogenic 
properties that contribute to tumor aggressiveness 
and invasiveness.  
Thus, our current study attempted to further 
elucidate the cellular and molecular profiles of these 
normal or hyperplastic appearing epithelia with cy-
toplasmic p63 expression, to assess: (1) whether they 
harbor aberrant expression of other tumor suppres-
sors or malignancy-associated changes, and (2) 
whether they differ substantially in DNA copy num-
bers compared to morphologically similar counter-
parts without cytoplasmic p63 expression.   
Materials and Methods 
 Formalin-fixed, paraffin-embedded tissue blocks 
from 20 cases of PABC used in our previous studies 
[11] were used for our current study. All cases were 
diagnosed during the pregnancy or within 3-months 
of postpoterm. No clinical following-up data, how-
ever, were available for these patients. For compari-
son, 20 cases of stage, grade, and age matched 
non-PABC were selected from the files of our institute 
and our own tissue bank. Consecutive sections at 4-5 
μm thickness were prepared and placed on positively 
charged slides. From each tissue block, the first and 
last sections were stained with hematoxylin and eosin 
(H&E) for morphological classification using our 
published criteria [16].  
To assess whether these normal or hyperplastic 
acini harbored aberrant expression of other tumor 
suppressors and malignancy associated alterations, 
two technical approaches were used. First, sets of six 
consecutive sections were immuno-stained for known 
tumor suppressors, including maspin (clone:EAW24), 
WT-1 (clone: 6F-H2), p63 (clone: 4A4), p53 
(clone:DO-7), p73 (clone:24) (Novocastra Laboratories 
Ltd, Newcastle, UK), and proliferation marker Ki-67 
(clone:MM1; Dako, Carpinteria, CA). The expression 
of these markers in myoepithelial and associated ep-
ithelial cells of the same acini at different sections 
were digitally photographed and reviewed under 
high magnification in a standard computer. Second, 
the physical distribution of these acini was examined 
to determine whether they were exclusively or prefe-
rentially associated or shared a similar morphological 
or immunohistochemical profile, with invasive le-
sions.  
  Immunohistochemistry for all antibodies was 
carried out using protocols provided by manufactur-
ers. Double immunohistochemistry was carried out 
using our published protocol [17]. To assess the spe-
cificity of immunostaining, three technical approaches 
were used. First, different controls, including (1) the 
substitution of the primary antibody with normal 
serum, (2) the omission of the secondary antibody 
from the immunostaining sequences, and (3) serial 
dilutions of the primary antibodies, were used. 
Second, the same immunostaining protocol was used 
on the same cases, but substituting with a different 
detection system and chromogen. Third, the immu-
nostaining procedure was repeated at least twice us-
ing the same protocol and under the same condition 
and immunostained sections were independently 
evaluated by two investigators. A given cell was con-
sidered immunoreactive when distinct immunoreac-
tivities were seen consistently in its membrane, cy-
toplasm, or nucleus, while all negative controls were 
devoid of immunostaining.  
To assess whether they differ substantially in 
DNA copy numbers compared to their morphologi-
cally similar counterparts without cytoplasmic p63 
expression, normal or hyperplastic lobules with uni-
form cytoplasmic p63 expression in acinar cells from 4 
PABC cases and morphologically comparable lobules 
(the same histological type, grade, and similar archi-
tecture and size) without cytoplasmic p63 expression 
from 4 non-PABC cases were microdissected with a 
30G1/2 needle, as previously described [18]. Micro-
dissected cells were subjected to DNA extraction and 
array-comparative genomic hybridization (ar-
ray-CGH).  
Array-CGH was carried out using previously 
published protocols [19,20] with minor modifications. 
Briefly, genomic DNAs were extracted and purified 
using a QIAamp Kit (Cat. No. 56404, QIAGEN, Va-
lencia, CA, USA) following the manufacturer’s in-
structions. The purity of each DNA sample was indi-Int. J. Biol. Sci. 2010, 6 
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cated by 1.8 of the A260/A280 ratio. Two micrograms 
of purified genomic DNA were labeled with fluores-
cent Cy3-dUTP using a DNA Labeling Kit (Cat. No. 
42671, Enzo Life Sciences, Farmingdale, NY, USA) 
following the manufacturer’s instructions. Hybridiza-
tion was carried out using a Human OneArray DNA 
microarray (Cat. # HOA004, Phalanx Biotech Group, 
Palo Alto, CA, USA) that contains 30,968 human ge-
nome probes and 1,082 experimental control probes. 
All microarray experiments for each DNA sample 
were performed in triplicate. 
Prior to data analysis, identification numbers, 
symbols and names of all genes on commercial chips 
were updated according to the Human UniGene Build 
#218 (ftp://ftp.ncbi.nih.gov/repository/UniGene/, 
January 5, 2009) using the probe ID and ENSG num-
ber came with the gene chips, since the original 
commercial annotation was based on the Human 
UniGene Build #163 (Cat. # HOA004, Phalanx Biotech 
Group). Gene ontology, chromosomal band regions, 
and phenotypes were compiled from Entrez 
(ftp://ftp.ncbi.nlm.nih.gov/gene) and DAVID Bio-
informatics Resources 2009 (http://david.abcc. 
ncifcrf.gov). 
The loss or gain of DNA copy numbers in PABC 
was calculated by comparison with those in 
non-PABC as previously described [19,20]. The ar-
ray-CGH database was constructed using the File-
Maker software (FileMaker Pro, Inc., Santa Clara, CA, 
USA). Data filtering and selection were performed as 
described previously [19]. The normalization method 
[21] in software R version 2.7.1 (The R Foundation for 
Statistical Computing) was used to normalize micro-
array data. The normalized data was used to compute 
the ratios of genomic DNA probes coding for each 
gene between PABC and controls, and to cluster genes 
based on similarities in gain or loss of DNA probes by 
using software Cluster version 3.0 [22]. Cluster tree 
and heatmap reflecting gain, loss, or no change in 
DNA probes of genes were visualized using software 
MapleTree (http://rana.lbl.gov/EisenSoftware.htm). 
Statistical calculations were performed on trip-
licate using XLSTAT 2006 (XLSTAT, New York, NY, 
USA). Gain or loss of DNA copy numbers were iden-
tified arbitrarily by >1.2-fold change in the averaged 
ratios of the background-subtracted mean intensities 
between PABC and non-PABC. Moderated t-statistic, 
raw p-values, log2 fold changes in DNA copy num-
bers, and false discovery rate (FDR) on multiple sta-
tistical testing were calculated using the LIMMA 
package in software R/Bioconductor (version 2.7.1, 
the R Foundation for Statistical Computing) [23]. To 
reveal biological functions of altered genes, gene on-
tology analysis was conducted to group genes based 
on their functions. The p-values for genes with func-
tional annotation report were calculated using a 
modified Fisher’s Exact Test (DAVID Bioinformatics 
Resources 2009; http://david.abcc.ncifcrf.gov/). Sta-
tistical significance was set at a p-value <0.05 and FDR 
≤ 5%.  
 As it is very difficult, if not impossible, to quan-
titatively measure the expression of mRNA or protein 
levels in formalin-fixed and paraffin-embedded tis-
sues, validation of the array-CGH results was con-
ducted using immunohistochemistry with specific 
antibodies to assess whether alterations detected by 
array-CGH correlated with in vivo protein expression 
in adjacent tissue sections. As a number of altered 
genes detected by array-CGH are essential for mor-
phogenesis, angiogenesis, adhesion, and macromo-
lecular complex assembly or intra-cellular trafficking 
[24-31], our study compared the vascular density, 
expression of cell adhesion molecules, and immuno-
reactivities of luminal secretory products between 
PABC and non-PABC with antibodies to Tenascin 
(clone:T2H5), E-cadherin (clone:36B5) (Lab Vision, 
Fremont, CA), D2-40 (clone:D2-40;Signet, Dedham, 
MA), CD34 (clone: QBEbd/10), CD45 (clone: 
2B11+PD7/26), and ß-catenin (clone: 17C2) (Dako, 
Carpinteria, CA). 
 Results 
All selected PABC and non-PABC cases con-
tained normal, hyperplastic, and neoplastic compo-
nents. The overall expression pattern and frequency 
of all antibodies were consistent with the description 
of the manufactures and those of our previous studies 
[9-11]. All negative controls were consistently devoid 
of immunoreactivities to any of these antibodies. Of 
20 PABC, 8 harbored a large number of epithelial cells 
arranged as lobules or large acinar clusters, in which 
all or near all cells uniformly expressed high levels of 
cytoplasmic p63, and 12 harbored variable numbers of 
cytoplasmic p63 expressing cells blended with cells 
without p63 expression. None of 20 non-PABC har-
bored epithelial cells with cytoplasmic p63 expres-
sion.  
 A vast majority of these lobules or acinal clusters 
with cytoplasmic p63 expression were segregated 
from their counterparts by inter-lobular stromal tis-
sues with a distinct boundary. In tissues that were not 
associated with, or distant from, malignant lesions, 
cytoplasmic p63 expression was seen in about 20-50% 
of the acinar cells, and nuclear p63 expression was 
seen in morphologically distinct myoepithelial cells 
(Fig 1a-d). In tissues associated with or adjacent to 
malignant lesions, cytoplasmic p63 expression was 
seen in all or nearly all normal or hyperplastic acinar Int. J. Biol. Sci. 2010, 6 
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cells, as well as adjacent cancer cells, while nuclear 
p63 expression was absent in all or nearly all mor-
phologically distinct myoepithelial cells (Fig 1e-h).  
Compared to their morphologically similar 
counterparts in non-PABC, these normal or hyper-
plastic lobules with cytoplasmic p63 expression 
showed the following unique alterations:  
1. Simultaneous reduction or loss of expression of multiple 
tumor suppressors  
In consecutive sections immunostained for dif-
ferent tumor suppressors, strong immunoreactivities 
to maspin were consistently seen in all or nearly all 
myoepithelial cells (Fig 2a-b). In contrast, only 10% to 
30% of maspin positive cells showed WT-1, p63, or 
p73 expression (Fig 2c-h).  
2. Morphological and immunohistochemical resemblance 
to invasive cancer cells 
These normal or hyperplastic lobules adjacent to 
invasive lesions consistently harbored isolated cells or 
cell clusters that were strongly immunoreactive to p53 
and Ki-67 (Fig 2i-l). These cells were exclusively lo-
cated at the site immediately adjacent to invasive le-
sions and shared a very similar immunohistochemical 
and morphological profile with invasive counterparts, 
which consistently showed diffuse cytoplasmic p63 
expression (Fig 3a-d). In addition, some isolated and 
morphologically distinct malignant cells with diffuse 
cytoplasmic p63 expression were consistently seen 
within these normal or hyperplastic lobules (Fig 3e-h).  
3. Significant gain or loss of DNA copy numbers in 45 
chromosomal loci in all 4 PABC cases  
Array-CGH detected significant DNA copy 
number changes in 45 chromosomal loci. Of these, 30 
showed significant gain (≥1.2 fold), and 15 showed 
significant loss (≤0.8 fold) in all PABC samples, com-
pared to non-PABC. Table 1 lists the chromosome 
band regions, statistic values, and harbored genes. 
The heat map and clusters in figure 4a-b visualize 
intuitive common differences of these 45 genes be-
tween the 4 paired DNA samples. 
4. Alterations in morphogenesis, angiogenesis, adhesion, 
and intra-cellular trafficking related genes 
The known corresponding genes with the ab-
normal genomic DNA belong to three functionally 
distinct but correlated groups (Table 2). Twenty genes 
(44.4%), including PBX4, SMC1B, KIF22, KCTD13, 
ARL17P1, ARHGAP6, NDUFS8, TNF, UBE2C, 
GOLGB1, HIST2H4B, NUP188, TBCC, MTA1, LOXL3, 
EGR4, SPARCL1, LRRC4,.DAP, and ATF1, are known 
to be involved in morphogenesis, angiogenesis, and 
organization of cellular components and organelles 
Nine genes (20%), including PBX4, KCTD13, NDUFS8, 
TNF, HIST2H4B, MUPCDH, KCDT3, GPR115, and 
ADAMTS17, are known to involve in macromolecular 
complex assembly and intra-cellular trafficking. Five 
genes (11.1%), including SMC1B, KIF22, TNF, UBE2C, 
and MTA, are known to involve in controlling the cell 
cycle.  
Array-CGH detected alterations in DNA copy 
numbers were in agreement with in vivo protein ex-
pression in adjacent tissue sections. In sections im-
munostained for angiogenesis-related marker D2-40 
and CD34, strong and uniform immunoreactivities, in 
addition to those seen in lymphatic ducts and blood 
vessels, were also seen, in myoepithelial cell layers, 
which often formed a ring-like structure surrounding 
each of the acini (Fig 5). In adjacent sections immu-
nostained for tenascin, a neonatal protein that facili-
tates early morphogenesis and tumor invasion [32], 
strong immunoreactivities were consistently detected 
within epithelial structures with focally disrupted 
myoepithelial cell layers, and also at the junctions 
between pre-invasive tissues and invasive lesions (Fig 
5e-f), which consistently harbored detached individ-
ual cells or cell clusters that were strongly immuno-
reactive to p53 (Fig 5g-h).  
In contrast to reduction or loss of tumor sup-
pressors in the myoepithelium, secretory products 
within the acinar lumen of most lobules in PABC were 
strongly immunoreactive to p63 and WT-1, but not to 
any of other antibodies used in the study. The pattern, 
intensity, and location of these immunoreactivities 
were similar with the peroxidase and alkaline phos-
phatase detection systems using DAB or AR-red 
chromogens (Fig 6). Pre-treatment with H2O2, lava-
mison, or biotin failed to eliminate or reduce immu-
noreactivities to WT-1 or p63. The substitution of the 
p63 and WT-1 primary antibodies with PBS or normal 
serum, however, resulted in total negativity (not 
shown). In sections immunostained for E-cadherin or 
beta-catenin, these acini consistently showed sub-
stantial reduction or absence of expression of these 
molecules, compared to their adjacent morphologi-
cally similar counterparts without cytoplasmic p63 
expression (not shown).  
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Table 1.  Significant gain or loss of DNA copy numbers in altered chromosomal loci of PABC 
 
Log-FC-T/C: log 2 of fold changes (FC) between tumor (T) and control (C) samples.  Moderated t-statistic, raw p-values, log2 fold changes in 
gene expression, and false discovery rate (FDR) on multiple statistical testing were calculated using the LIMMA package in software 
R/Bioconductor.  The statistical significance was set at a p-value <0.05 and FDR ≤ 5%. 
 
Table 2. Biological functions and names of known genes affected by their genomic DNA gain or loss in PABC 
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Figure 1. Acinar cell clusters or lobules with cytoplasmic p63 expression. Sections from paraffin embedded 
tissues of PABC were immunostained for p63 (brown or red). Circles identify normal appearing lobules in which all acinar 
cells show cytoplasmic p63 expression.  Thin and thick arrows identify cells with nuclear and cytoplasmic p63 expression, 
respectively.  Asterisks identify invasive tissue components.  In tissues without or distant from malignant lesions, both 
cytoplasmic and nuclear p63 expression cells are seen (a-d), whereas in tissues harbored or adjacent to malignant lesions 
(e-h), all or nearly all cells within a given lobule uniformly show high levels of cytoplasmic p63 expression.   a, c, e, and g: 
100X;  b, d, f, and h: a higher (300X) magnification of a, c, e, and g, respectively.  Int. J. Biol. Sci. 2010, 6 
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Figure 2. Reduced expression of other tumor suppressors in myoepithelium of PABC. A set of 6 consecutive 
sections of PABC were immunostained for maspin, WT-1, p63, p73, p53, and Ki-67, respectively. Circles identify normal 
appearing lobules in which all or nearly all acinar cells show cytoplasmic p63 expression. Thick arrows identify the myoe-
pithelial cell layer in different sections.  Thin arrows identify isolated tumor cells with p53 and Ki-67 expression. Note that 
all or nearly all the myoepithelial cells uniformly express maspin, whereas only about 10-30% of maspin positive cells show 
WT-1, p63, or p73 expression. Also note that these normal appearing lobules harbor some isolated p53 positive tumor cells 
and have an elevated cell proliferation index. a, c, e, g, I, and k: 80X; b, d, f, h, j, and l: a higher magnification (200X) of a, c, 
e, g, I, and k, respectively.  Int. J. Biol. Sci. 2010, 6 
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Figure 3. Morphological and immunohistochemical resemblance to invasive cancer cells. Sections from 4 
PABC cases were immunostained for p63 (brown).  Circles identify normal or hyperplastic lobules in which all or nearly all 
cells show high levels of cytoplasmic p63 expression.  Arrows identify adjacent invasive cancer cells.  Note that some cells 
within these normal or hyperplastic appearing lobules and their adjacent invasive counterparts share a very similar im-
munohistochemical or morphological profile. a, c, e, and g: 100X;  b, d, f, and h: a higher (300) magnification of a, c, e, and g, 
respectively.  Int. J. Biol. Sci. 2010, 6 
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Figure 4. Significant gain or loss of DNA copy numbers in lobules with cytoplasmic p63 expression. Micro-
dissected cells from 4 cases of PABC and 4 cases of morphologically similar non-PABC were subjected to array-CGH.  Gain 
or loss of DNA copy numbers were identified arbitrarily by >1.2-fold change in the average of the background-subtracted 
mean intensity ratios between PABC and control samples.  (A) Data normalization; (B) Heat map and clusters; (C) Control 
samples. The triplicate microarray experiments were performed for each sample. Int. J. Biol. Sci. 2010, 6 
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Figure 5. Elevated expression of angiogenesis and growth-related genes. A set of four consecutive sections 
adjacent to sections used for array-CGH were immunostained for morphogenesis and angiogenesis-related biomarkers. 
Arrows identify aberrant expression of D2-40 and CD34 in myoepithelial cell layers, and aberrant expression of tenascin and 
p53 at the junctions between pre-invasive tissues and invasive lesions. Note that significantly higher expression of these 
markers were seen in normal appearing lobules adjacent to, compared to those distant from, invasive lesions (asterisks).  a, 
c, e, and g: 80X;  b, d, f, and h: a higher (200) magnification of a, c, e, and g, respectively. Int. J. Biol. Sci. 2010, 6 
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Figure 6. Elevated expression of macromolecular complex assembly and intra-cellular trafficking related 
genes. Two sets of four consecutive sections adjacent to sections used for array-CGH were immunostained for p63, WT-1, 
and maspin.  Circles identify acinal lumen with high level of secretory products.  Note that strong p63 and WT-1 immu-
noreactivities were seen in these luminal secretory products, while maspin is only seen in the myoepithelium. 100X. 
 Int. J. Biol. Sci. 2010, 6 
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Discussion and Conclusions 
The overall expression pattern of p63 expression 
in the myoepithelium and biological presentations in 
associated epithelium seen in our current study are in 
total agreement with those of our previous studies 
[9-11] and reports from other groups [5-8]. Our cur-
rent study, however, has detected several unique al-
terations in normal or hyperplastic tissues of PABC 
that have not been previously reported, including: (1) 
immunohistochemical and morphological resem-
blance to adjacent invasive cancer, (2) significant gain 
of DNA copy number in chromosomal loci harbored 
morphogenesis, angiogenesis, and metastasis related 
genes, including early growth response 4, lysyl oxi-
dase-like 3, and metastasis associated 1 [24-26, 29], 
and (3) significant loss of DNA copy number in 
chromosomal loci harbored tumor suppressor, cell 
adhesion, and macromolecular complex assembly or 
intra-cellular trafficking related genes, including 
Sparc-like 1, cytohesion 1 interacting protein, and 
G-protein coupled receptor115 [27,28,31]. Detected 
array-CGH alterations correlated well with in vivo 
expression of a number of corresponding proteins 
tested.  
 Together, our findings suggest that normal or 
hyperplastic appearing acinar cells with cytoplasmic 
p63 expression may represent a biologically more 
aggressive cell population, which could potentially 
progress to invasive lesions without undergoing 
through the stage of in situ cancer. Consistent with 
this possibility are a number of reports: (1) a subset of 
morphologically normal breast tissues share similar 
genetic and immunohistochemical profiles with ma-
lignant counterparts [33-35], (2) some “healthy” men 
between 19 and 29 years old had a spectrum of le-
sions, including hyperplasia and adenocarcinoma 
[36], (3) prostate tissues from some “healthy” men or 
morphologically normal prostate tissues harbored a 
DNA phenotype that is identical to that of prostate 
cancer [37,38], and (4) significant gene expression 
abnormalities were detected with microarrays using 
RNA extracted from microdissected histologically 
normal terminal ductal-lobular units (TDLU) of some 
breast tissues [39].  
Normal or hyperplastic appearing acini with 
cytoplasmic p63 expression are likely to be formed 
from genetically altered progenitors for two main 
reasons: (1) TD and TDLU are the primary, if not the 
exclusive, site of progenitor cells, and (2) A vast ma-
jority of breast malignancies are derived from TDLU, 
which recapitulates the processes of early morpho-
genesis [40,41]. The formation of altered TD and as-
sociated acini is likely to result from two correlated 
pathways:  (A) Genetic defects in myoepithelial cell 
self-renewal-related genes. As both p63 and WT-1 play 
significant roles in the early developmental of several 
organs and systems [42,43], it is possible that at the 
early stage of breast morphogenesis, the breasts of 
these patients may have exposed to certain external or 
internal insults that may have been causing perma-
nent damages in DNA structures of some primitive 
stem cells. These DNA structural damages resulted in 
the inactivation of, or defects in, myoepithelial cell 
renewal-related genes, which impaired the myoepi-
thelial cell replenishment process to replace the aged 
or injured myoepithelial cells, resulting in a “se-
nesced” myoepithelial cell population with signifi-
cantly reduced p63 and WT-1 expression. Consistent 
with this possibility is the fact that the expression of 
maspin, a tumor suppressor that is not involved in 
early development [6], is not affected in all PABC 
cases in this study. (B) Simultaneous activation and pro-
liferation of multiple tumor stem cells. The DNA struc-
tural damages may have also caused the inactivation 
of, or defects in, cell cycle control- and apopto-
sis-related genes in the epithelial cell population, 
which allow these cells to proliferate to form clusters 
of ducts or acini with the same genetic defects. These 
acinar or duct clusters may progress rapidly after ex-
ternal or internal insults, leading to the early occur-
rence of breast cancer at young ages. On the other 
hand, these clusters may become maturation-arrested 
after a few cycles of cells divisions, but retain the po-
tential for unlimited proliferation and multi-lineage 
differentiation [44]. During the last few weeks of 
pregnancy, these clusters are activated and simulta-
neously proliferating in responding to a sharp in-
crease of estrogen, progesterone, and other hormones 
[1-3]. In agreement with this possibility is the fact that 
clinical morphological examinations have shown that 
a vast majority of the breast tumors are generally 
confined within a “sick” lobe [45].  
Our immunohistochemical studies consistently 
showed a significant reduction or loss of nuclear p63 
and WT-1 expression in a vast majority of the myoe-
pithelial cells, while significantly increased cytoplas-
mic p63 expression in associated epithelial cells in 
PABC. Our array-CGH, however, failed to detect sig-
nificant gain or loss in the genomic DNA that harbor 
genes coding for these two proteins. This disparity 
could potentially result from the following epigenetic 
alterations:  (1) Aberrant intra-cellular transportation of 
the p63 protein. Similar to the p53 protein, p63 is syn-
thesized in the cytoplasm and constantly transported 
through the nuclear pore complex into the nuclei 
[46,47]. A number of factors, including alterations of 
the elements and molecules involved in p63 nuc-Int. J. Biol. Sci. 2010, 6 
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leo-cytoplasmic transportation could significantly 
impact the p63 intra-cellular trafficking, and conse-
quently alter its sub-cellular localization [46,47]. (2) 
Formation of protein-protein complexes. A previous study 
from our lab showed that only cells exhibiting secre-
tory changes or secretory carcinomas had cytoplasmic 
p63 expression [48]. Thus, it is possible that secretory 
products in PABC may form protein-protein com-
plexes with p63, which prevent the import of p63 
protein into the nuclei. Consistent with this possibility 
is the fact that some proteins could form pro-
tein-protein complexes with p53, which results in ac-
cumulation of p53 in the cytoplasm [46]. (3) Interac-
tions with WT-1 protein, which results in the secretion of 
both proteins into the acinar lumen. Consistent with this 
possibility is the fact that the secretory products 
within the acinar lumen of most lobules in PABC were 
strongly and uniformly immunoreactive to antibodies 
against p63 and WT-1, but not to any of other antibo-
dies used in the study. In addition, our array-CGH 
analyses detected a number of factors that are closely 
involved in cellular organelle and molecular organi-
zation and transportation. Since previous studies have 
shown that cytoplasmic localization of p63 is asso-
ciated with poor patient survival in lung cancer and is 
also associated with tumor grade in meningiomas 
[14,15], aberrant expression and sub-cellular localiza-
tion of p63 and WT-1 may represent a novel mechan-
ism for tumor aggressiveness and invasiveness. If 
confirmed, our findings could have significant impli-
cations: (1) changes of the tissue microenvironment 
may have direct impact on carcinogenesis, and (2) 
manipulation of the sub-cellular localization may 
have significant therapeutic value.  
The specific cellular or molecular mechanism 
accounting for a correlation between tumor suppres-
sor expression in the myoepithelium and biological 
behavior in the associated epithelium is unknown, but 
it is likely to result from aberrant tumor suppressor 
expression and focal disruptions in the myoepithe-
lium. As the epithelium is normally devoid of both 
blood vessels and lymphatic ducts, and thus, totally 
relies on the stroma for its needed materials for nor-
mal functions and even survival, a focal myoepithelial 
cell layer disruption could have several consequences, 
including (1) an increase of permeability for oxygen, 
nutrients, and growth factors, which selectively trig-
gers the exit of stem or progenitor cells from quies-
cence [49], (2) exposure of luminal cells to different 
cytokines, which facilitates tumor angiogenesis [50], 
(3) physical contact between luminal and stromal 
cells, which facilitates epithelial-mesenchymal transi-
tion (EMT) and cell motility [51],  and (4) physical 
contact between luminal and immunoreactive cells, 
which directly cause genomic or cellular damages that 
trigger a cascade reaction of malignant transformation 
[52]. Consistent with these possibilities are the facts 
that our array-CGH revealed that all 4 PABC cases 
had a significant gain or loss in their genomic DNA 
harboring genes involved in morphogenesis, angi-
ogenesis, and controlling the cell cycle.  
No definite conclusions, however, could be 
drawn at present for two main reasons: (1) our study 
is the first one to assess the correlation between 
myoepithelia and associated epithelia in PABC with 
array-CGH and immunohistochemistry, and (2) our 
sample size is small and the clinical follow-up data are 
not available. On the other hand, if confirmed, our 
study will be the first one to provide in vivo evidence 
that suggests a correlation between reduced tumor 
suppressor expression in the myoepithelium and in-
vasive behavior in the associated epithelium. Since 
degradation of the myoepithelium is an absolute 
pre-requisite for breast tumor invasion, our findings 
would have significant implications. Scientifically, 
these would suggest that the development of thera-
peutic agent to stimulate myoepithelial cell 
self-renewal or to prevent myoepithelial cell degra-
dation may be more effective than the traditional ap-
proaches for breast cancer intervention and preven-
tion. Clinically, as a vast majority of the breast ma-
lignancies are originated from TDLU, the develop-
ment of more applicable methods to quantitatively 
assess the expression of p63 and WT-1 expression in 
this site may be more effective than other approaches 
for early detection of breast cancer. In addition, the 
elucidation of the mechanism of cytoplasmic p63 ex-
pression may lead to the development of new thera-
peutic agents to target cancer-related molecules in the 
cytoplasm or even in nuclei. 
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